SELLAS Life Sciences (SLS) Announces Proposed Stock Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. LULU
4. DVN
5. WOLF
6. ANGO
7. COST
8. BCO
9. NATL
10. STZ

Go back to SELLAS Life Sciences (SLS) Announces Proposed Stock Offering

SELLAS Life Sciences Announces Proposed Underwritten Public Offering

February 23, 2023 4:01 PM EST

NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) ("SELLAS" or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock. All of the securities in the offering will be sold by SELLAS.

Cantor Fitzgerald & Co. is acting as the sole book-running... More